DE69430902T2 - C2-Taxan-Derivate sowie diese enthaltende Arzneimittel - Google Patents

C2-Taxan-Derivate sowie diese enthaltende Arzneimittel

Info

Publication number
DE69430902T2
DE69430902T2 DE69430902T DE69430902T DE69430902T2 DE 69430902 T2 DE69430902 T2 DE 69430902T2 DE 69430902 T DE69430902 T DE 69430902T DE 69430902 T DE69430902 T DE 69430902T DE 69430902 T2 DE69430902 T2 DE 69430902T2
Authority
DE
Germany
Prior art keywords
taxane derivatives
products containing
medicinal products
substituent
taxane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69430902T
Other languages
English (en)
Other versions
DE69430902D1 (de
Inventor
A Holton
Chunlin Tao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Florida State University
Original Assignee
Florida State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/010,798 external-priority patent/US5399726A/en
Application filed by Florida State University filed Critical Florida State University
Publication of DE69430902D1 publication Critical patent/DE69430902D1/de
Application granted granted Critical
Publication of DE69430902T2 publication Critical patent/DE69430902T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69430902T 1993-01-29 1994-01-28 C2-Taxan-Derivate sowie diese enthaltende Arzneimittel Expired - Fee Related DE69430902T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/010,798 US5399726A (en) 1993-01-29 1993-01-29 Process for the preparation of baccatin III analogs bearing new C2 and C4 functional groups
US3485293A 1993-03-22 1993-03-22
US9471593A 1993-07-20 1993-07-20
PCT/US1994/001223 WO1994017052A1 (en) 1993-01-29 1994-01-28 C2 taxane derivatives and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
DE69430902D1 DE69430902D1 (de) 2002-08-08
DE69430902T2 true DE69430902T2 (de) 2002-10-24

Family

ID=27359309

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69430902T Expired - Fee Related DE69430902T2 (de) 1993-01-29 1994-01-28 C2-Taxan-Derivate sowie diese enthaltende Arzneimittel
DE69430661T Expired - Fee Related DE69430661T2 (de) 1993-01-29 1994-01-31 Verfahren zur Herstell ung von Baccatin III-Analogen, Verbindungen mit neuen funktionellen Gruppen an C2 und C4

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69430661T Expired - Fee Related DE69430661T2 (de) 1993-01-29 1994-01-31 Verfahren zur Herstell ung von Baccatin III-Analogen, Verbindungen mit neuen funktionellen Gruppen an C2 und C4

Country Status (13)

Country Link
EP (2) EP0681573B1 (de)
JP (2) JP3452928B2 (de)
CN (1) CN1125061C (de)
AT (2) ATE220064T1 (de)
AU (2) AU685778B2 (de)
CA (2) CA2155013C (de)
DE (2) DE69430902T2 (de)
DK (1) DK0681573T3 (de)
ES (1) ES2176237T3 (de)
IL (1) IL108444A0 (de)
PT (1) PT681573E (de)
TW (2) TW360646B (de)
WO (2) WO1994017052A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710287A (en) 1991-09-23 1998-01-20 Florida State University Taxanes having an amino substituted side-chain and pharmaceutical compositions containing them
IL108443A0 (en) * 1993-01-29 1994-04-12 Univ Florida State C7 taxane derivatives and pharmaceutical compositions containing them
FR2702212B1 (fr) * 1993-03-02 1995-04-07 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
US5677470A (en) * 1994-06-28 1997-10-14 Tanabe Seiyaku Co., Ltd. Baccatin derivatives and processes for preparing the same
FR2723094A1 (fr) * 1994-07-26 1996-02-02 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
CA2162759A1 (en) * 1994-11-17 1996-05-18 Kenji Tsujihara Baccatin derivatives and processes for preparing the same
WO1998013359A1 (de) * 1996-09-24 1998-04-02 Marigen S.A. Ultramikroemulsionen aus spontan dispergierbaren konzentraten mit antitumoral und antiviral wirksamen estern von baccatin-iii-verbindungen
IL139218A0 (en) * 1997-12-31 2001-11-25 Virginia Tech Intell Prop 2-aroyl-4-acyl-paclitaxel (taxol) analogs
ITMI20021921A1 (it) * 2002-09-10 2004-03-11 Indena Spa Funzionalizzazione della posizione 14 dei nuclei tassanici e sintesi di nuovi derivati antitumorali.
BRPI0511109A (pt) * 2004-05-14 2007-11-27 Immunogen Inc método fácil para sintetizar compostos de baccatin iii
US20130090484A1 (en) * 2011-10-11 2013-04-11 Scinopharm Taiwan Ltd. Process for making an intermediate of cabazitaxel
CN104250235B (zh) * 2014-09-24 2016-10-05 江苏红豆杉药业有限公司 一种紫杉醇的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4942184A (en) * 1988-03-07 1990-07-17 The United States Of America As Represented By The Department Of Health And Human Services Water soluble, antineoplastic derivatives of taxol

Also Published As

Publication number Publication date
DK0681573T3 (da) 2002-10-28
EP0681575B1 (de) 2002-05-22
DE69430902D1 (de) 2002-08-08
CN1125061C (zh) 2003-10-22
ATE217870T1 (de) 2002-06-15
TW402598B (en) 2000-08-21
WO1994017051A1 (en) 1994-08-04
EP0681575A4 (de) 1995-12-13
JPH08506326A (ja) 1996-07-09
AU684268B2 (en) 1997-12-11
IL108444A0 (en) 1994-04-12
AU685778B2 (en) 1998-01-29
ATE220064T1 (de) 2002-07-15
PT681573E (pt) 2002-11-29
AU6132794A (en) 1994-08-15
EP0681575A1 (de) 1995-11-15
CA2155013A1 (en) 1994-08-04
TW360646B (en) 1999-06-11
JP3452928B2 (ja) 2003-10-06
DE69430661D1 (de) 2002-06-27
JP3741715B2 (ja) 2006-02-01
AU6234094A (en) 1994-08-15
EP0681573A4 (de) 1995-12-06
EP0681573B1 (de) 2002-07-03
CA2155014C (en) 2007-06-26
ES2176237T3 (es) 2002-12-01
CA2155013C (en) 2006-04-11
DE69430661T2 (de) 2002-10-24
CN1101346A (zh) 1995-04-12
JPH10502327A (ja) 1998-03-03
CA2155014A1 (en) 1994-08-04
WO1994017052A1 (en) 1994-08-04
EP0681573A1 (de) 1995-11-15

Similar Documents

Publication Publication Date Title
TR199800825T2 (xx) Farnesil protein transferini inhibe eden (imidazol-5-il) metil-2-kinolinon t�revleri.
FI914723A0 (fi) 17b-substituerade 4-aza-5a-androstan -3-jon-derivat och foerfarande foer framstaellning av desamma.
FI943749A (fi) Taksaanijohdannaisten fosfono-oksimetyylieetterit
TR199901174T2 (xx) Yeni heterosiklilmetil-ikameli pirazol t�revleri.
IL123002A0 (en) 1-Phenyl-2- phenylacetoxy- ethanone derivatives
FI953467A (fi) Aminohappojohdannaisia, näitä yhdisteitä sisältävät lääkeaineet ja menetelmä niiden valmistamiseksi
ATE197672T1 (de) Arzneimittel gegen nervöse erkrankungen
TR199800019T1 (xx) Trombosit topaklanmas�n� �nleyici yeni maddeler.
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
DE69430902D1 (de) C2-Taxan-Derivate sowie diese enthaltende Arzneimittel
PT741716E (pt) Analogos de delta 12,13-iso-taxol sua utilizacao anti-neoplasica e composicoes farmaceuticas que os contem
PT929565E (pt) Esteres de nitrato de compostos corticoides e suas aplicacoes farmaceuticas
FI973440A0 (fi) Trisubstituoituja fenyylijohdannaisia
ES2122637T3 (es) Derivados de tiazolidina, su preparacion y los medicamentos que les contienen.
ATE236142T1 (de) C7-taxan-derivate sowie diese enthaltende arzneimittel
MX9300628A (es) Nuevos derivados de taxano, procedimiento para su preparacion y composicion farmaceutica que los contiene.
ATE207076T1 (de) Ara-c derivate
EA200000242A1 (ru) Применение фанхинона для лечения болезни альцгеймера
TR199701298T1 (xx) Tetralinler.
BR0016941A (pt) Derivados de aminometil-fenil-ciclohexanona
PT1000067E (pt) Tiazolobenzo-heterociclos sua preparacao e medicamentos que os contem
FR2707496B1 (fr) Compositions pharmaceutiques antiradicalaires et/ou antilipoperoxydantes et/ou hépatotropes.
NO20020914D0 (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
JPS52100439A (en) Omega-(arysulfonamido)alkylamines
DE69503635T2 (de) Pyrrolidinderivate zur behandlung von cck und gastrin-abhängigen erkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee